Read journal articles, abstracts and other clinical evidence related to cardiac monitoring and Confirm Rx™ ICM with SharpSense™ technology.
PACE. Sept. 24, 2020. Ip J, Jaffe B, Castellani M, et al.
Conclusion: Compared to the Reveal LINQ, Confirm Rx has shorter event transmission time, more frequent event detections, shorter duration to diagnose true arrhythmic events, and higher percentage of diagnosed patients.
International Journal of Cardiology, 231, 170-176. Solbiati, M., Casazza, G., Dipaola, F., Barbic, F., Caldato, M., Montano, N., ... Costantino, G. (2017).
Conclusion: About half of unexplained syncope subjects implanted with an ILR were diagnosed, and around 50% of them had an arrhythmia. Life-threatening arrhythmias as well as ILR complications and death due to arrhythmic events were very rare.
Journal of Cardiovascular Electrophysiology. . 10.1111/jce.13089. Nölker, Georg & Mayer, Julia & Boldt, Leif-Hendrik & Seidl, Karlheinz & Van Driel, Vincent & Massa, Thomas & Kollum, Marc & Brachmann, Johannes & Deneke, Thomas & Hindricks, Gerhard & Jung, Werner & J. Brunner, Kyle & Kraus, Stacia & Hummer, Alexander & Lewalter, Thorsten. (2016).
Conclusion: The Confirm Rx predecessor, Confirm DM2102 ICM can accurately and repeatedly detect paroxysmal AF episodes of at least 2 minutes in length.
Cryptogenic Stroke and Underlying Atrial Fibrillation.
The New England Journal of Medicine, 370(26), 2478-2486. doi:10.1056/NEJMoa1313600. Sanna, T., M.D., Diener, H., M.D., Ph.D., Passman, R. S., M.D., M.S.C.E., Di Lazzaro, V., M.D., Bernstein, R. A., M.D., Ph.D., Morillo, C. A., M.D., ... Brachmann, J., M.D. (2014).
Conclusion: ECG monitoring with an ICM was superior to conventional follow-up for detecting atrial fibrillation after cryptogenic stroke.
MAT-2012205 v1.0
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.
Do you want to continue?